These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38382667)
1. A growth factor-reduced culture system for colorectal cancer organoids. Tan R; Zhang Z; Ding P; Liu Y; Liu H; Lu M; Chen YG Cancer Lett; 2024 Apr; 588():216737. PubMed ID: 38382667 [TBL] [Abstract][Full Text] [Related]
2. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer. Xie BY; Wu AW Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340 [TBL] [Abstract][Full Text] [Related]
3. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis. Wang R; Mao Y; Wang W; Zhou X; Wang W; Gao S; Li J; Wen L; Fu W; Tang F Genome Biol; 2022 Apr; 23(1):106. PubMed ID: 35484598 [TBL] [Abstract][Full Text] [Related]
4. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma. Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618 [TBL] [Abstract][Full Text] [Related]
5. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling. Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510 [TBL] [Abstract][Full Text] [Related]
6. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance. Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111 [TBL] [Abstract][Full Text] [Related]
7. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer. Cristobal A; van den Toorn HWP; van de Wetering M; Clevers H; Heck AJR; Mohammed S Cell Rep; 2017 Jan; 18(1):263-274. PubMed ID: 28052255 [TBL] [Abstract][Full Text] [Related]
8. SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation. Costa D; Venè R; Coco S; Longo L; Tosetti F; Scabini S; Mastracci L; Grillo F; Poggi A; Benelli R Cells; 2023 Feb; 12(4):. PubMed ID: 36831331 [TBL] [Abstract][Full Text] [Related]
9. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer. Toshimitsu K; Takano A; Fujii M; Togasaki K; Matano M; Takahashi S; Kanai T; Sato T Nat Chem Biol; 2022 Jun; 18(6):605-614. PubMed ID: 35273398 [TBL] [Abstract][Full Text] [Related]
10. Use of Organoids to Characterize Signaling Pathways in Cancer Initiation. Oatway C; Hirsch CL; Gregorieff A Methods Mol Biol; 2018; 1765():315-331. PubMed ID: 29589318 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study. Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991 [TBL] [Abstract][Full Text] [Related]
12. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. Fujii M; Shimokawa M; Date S; Takano A; Matano M; Nanki K; Ohta Y; Toshimitsu K; Nakazato Y; Kawasaki K; Uraoka T; Watanabe T; Kanai T; Sato T Cell Stem Cell; 2016 Jun; 18(6):827-838. PubMed ID: 27212702 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics. Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK-dependent colorectal cancer. Shimizu S; Kondo J; Onuma K; Coppo R; Ota K; Kamada M; Harada Y; Tanaka Y; Nakazawa MA; Tamada Y; Okuno Y; Kawada K; Obama K; Coffey RJ; Fujiwara Y; Inoue M Cancer Sci; 2023 Sep; 114(9):3636-3648. PubMed ID: 37357017 [TBL] [Abstract][Full Text] [Related]
16. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009 [TBL] [Abstract][Full Text] [Related]
17. The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer. Wang Z; Zhou L; Wang Y; Peng Q; Li H; Zhang X; Su Z; Song J; Sun Q; Sayed S; Liu S; Lu D Theranostics; 2021; 11(9):4421-4435. PubMed ID: 33754069 [No Abstract] [Full Text] [Related]
18. A Bioinformatic Profile of Gene Expression of Colorectal Carcinoma Derived Organoids. A P; Xu X; Wang C; Ye L; Yang J Biomed Res Int; 2018; 2018():2594076. PubMed ID: 30363662 [TBL] [Abstract][Full Text] [Related]
19. Specific metabolic response of patient-derived organoids to curcumin of colorectal cancer. Chen L; Dai Z; Ge C; Huang D; Zhou X; Pan K; Xu W; Fu J; Du JL J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jul; 1203():123260. PubMed ID: 35598460 [TBL] [Abstract][Full Text] [Related]
20. [Effects of biomechanics on colorectal organoid culture]. Qian X; Sun X; Liang Y; Yang L Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1309-1322. PubMed ID: 38783799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]